🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

22 recruiting trials

for Any Cancer

A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors NCT06126666Phase 13 sites📍 Seongnam📍 Seoul📍 Seoul ABL Bio, Inc. · Tests: ABL103 Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars NCT06375941n/a19 sites📍 Rozzano📍 Aviano📍 Orbassano Italian Sarcoma Group · Tests: Observational Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM NCT07109323Phase 1, Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: BCMA CART Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors NCT04165772Phase 210 sites📍 Hartford📍 Miami📍 Basking Ridge Memorial Sloan Kettering Cancer Center · Tests: TSR-042 or Dostarlimab, capecitabine or 5-FU, Intensity Modulated Radiation Therapy (IMRT) Donor Site Morbidity After Free Vascularized Fibular Graft NCT06324916n/a1 site📍 Asyut Assiut University · Tests: Xray PROACT is a Prospective Master Protocol for a Cohort Study Focused on Evaluating the Implementation of Integrated Proactive Supportive Care Pathways at Gustave Roussy NCT06479057n/a1 site📍 Villejuif Gustave Roussy, Cancer Campus, Grand Paris · Tests: Supportive Care Pathway Is the 1939 Cancer Act Fit for Purpose in the Modern Technology Era? NCT07584824n/a1 site📍 Truro Royal Cornwall Hospitals Trust WellSpan-THRIVE Cancer QOL Study NCT07433660n/a5 sites📍 Chambersburg📍 Ephrata📍 Gettysburg WellSpan Health A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer NCT06984861Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: 18F-FMISO PET/CT Scan, Chemoradiation, Questionnaires Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities NCT07572396Phase 21 site📍 Shatin Amplexd Therapeutics, Inc. · Tests: EGCG and Quinine Sulfate Vaginal Suppository, Placebo High Definition Medicine for Solid Tumors Oncology NCT06590506n/a9 sites📍 A Coruña📍 Fuenlabrada📍 Palma de Mallorca Centro Nacional de Investigaciones Oncologicas CARLOS III · Tests: Wearable Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype NCT06753136NA1 site📍 Padova Istituto Oncologico Veneto IRCCS · Tests: percutaneous, laparoscopic or laparotomy lesion electrochemotherapy Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases NCT07098806Phase 1, Phase 21 site📍 San Antonio Cerenome · Tests: 186RNL GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer NCT05415007NA1 site📍 San Francisco Stanford University · Tests: GOLD Program, Treatment as usual (TAU) Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors NCT05746208Phase 21 site📍 San Francisco University of California, San Francisco · Tests: Lenvatinib, Pembrolizumab, Hyperpolarized 13C-Pyruvate Phase II Trial of Lung Chemoemobolization NCT05672108Phase 22 sites📍 Duarte📍 New York City of Hope Medical Center · Tests: Computed Tomography, Ethiodized Oil, Mitomycin, Transarterial Chemoembolization, Tris-acryl Gelatin Microspheres AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors NCT06911333Phase 1, Phase 23 sites📍 Seongnam-si📍 Seoul📍 Seoul Avelos Therapeutics Inc. · Tests: AD1208 VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites📍 Santa Rosa📍 Hartford📍 Washington D.C. VM Oncology, LLC · Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) Brain Connectivity Changes in Glioma Patients During Treatment NCT07612917n/a1 site📍 Linz Johannes Kepler University of Linz This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors NCT04762641Phase 18 sites📍 Duarte📍 Los Angeles📍 Santa Monica ABL Bio, Inc. · Tests: ABL503 Pancreatic Cancer Registry: For Any Person With a Personal or Family History NCT02886247n/a1 site📍 Baltimore Johns Hopkins University French Clinical Datbase of Melanoma Patients (RIC-Mel) NCT03315468n/a1 site📍 Nantes Nantes University Hospital
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy